KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $6.8 million.

  • Medpace Holdings' Depreciation and Depletion fell 481.98% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 127.01%. This contributed to the annual value of $27.8 million for FY2024, which is 1524.72% up from last year.
  • Latest data reveals that Medpace Holdings reported Depreciation and Depletion of $6.8 million as of Q3 2025, which was down 481.98% from $6.8 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Depreciation and Depletion registered a high of $7.2 million during Q3 2024, and its lowest value of $3.8 million during Q1 2021.
  • Moreover, its 5-year median value for Depreciation and Depletion was $6.0 million (2023), whereas its average is $5.6 million.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first surged by 5540.15% in 2021, then plummeted by 481.98% in 2025.
  • Quarter analysis of 5 years shows Medpace Holdings' Depreciation and Depletion stood at $4.2 million in 2021, then increased by 21.17% to $5.1 million in 2022, then rose by 26.62% to $6.4 million in 2023, then increased by 11.26% to $7.1 million in 2024, then decreased by 4.65% to $6.8 million in 2025.
  • Its last three reported values are $6.8 million in Q3 2025, $6.8 million for Q2 2025, and $6.7 million during Q1 2025.